Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor

Much attention has recently been devoted to the life and behaviour of pharmaceuticals in the water cycle. In this study the behaviour of several pharmaceutical products in different therapeutic categories (analgesics and anti-inflammatory drugs, lipid regulators, antibiotics, etc.) was monitored during treatment of wastewater in a laboratory-scale membrane bioreactor (MBR). The results were compared with removal in a conventional activated-sludge (CAS) process in a wastewater-treatment facility. The performance of an MBR was monitored for approximately two months to investigate the long-term operational stability of the system and possible effects of solids retention time on the efficiency of removal of target compounds. Pharmaceuticals were, in general, removed to a greater extent by the MBR integrated system than during the CAS process. For most of the compounds investigated the performance of MBR treatment was better (removal rates >80%) and effluent concentrations of, e.g., diclofenac, ketoprofen, ranitidine, gemfibrozil, bezafibrate, pravastatin, and ofloxacin were steadier than for the conventional system. Occasionally removal efficiency was very similar, and high, for both treatments (e.g. for ibuprofen, naproxen, acetaminophen, paroxetine, and hydrochlorothiazide). The antiepileptic drug carbamazepine was the most persistent pharmaceutical and it passed through both the MBR and CAS systems untransformed. Because there was no washout of biomass from the reactor, high-quality effluent in terms of chemical oxygen demand (COD), ammonium content (N-NH4), total suspended solids (TSS), and total organic carbon (TOC) was obtained.

[1]  Walter Giger,et al.  Trace determination of macrolide and sulfonamide antimicrobials, a human sulfonamide metabolite, and trimethoprim in wastewater using liquid chromatography coupled to electrospray tandem mass spectrometry. , 2004, Analytical chemistry.

[2]  T. Poiger,et al.  Occurrence and Environmental Behavior of the Chiral Pharmaceutical Drug Ibuprofen in Surface Waters and in Wastewater , 1999 .

[3]  H. Kroiss,et al.  The solids retention time-a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. , 2005, Water research.

[4]  E. Thurman,et al.  Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. , 2002 .

[5]  Walter Giger,et al.  Occurrence and fate of antibiotics as trace contaminants in wastewaters, sewage sludges, and surface waters , 2003 .

[6]  Xianghua Wen,et al.  Ultrafiltration membrane bioreactor for urban wastewater reclamation , 2000 .

[7]  M. Servos,et al.  Occurrence of neutral and acidic drugs in the effluents of Canadian sewage treatment plants , 2003, Environmental toxicology and chemistry.

[8]  P. Jjemba.  Excretion and ecotoxicity of pharmaceutical and personal care products in the environment. , 2006, Ecotoxicology and environmental safety.

[9]  H Kroiss,et al.  Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. , 2005, Water research.

[10]  Nazim Cicek,et al.  Effectiveness of the membrane bioreactor in the biodegradation of high molecular weight compounds , 1998 .

[11]  T. Tuhkanen,et al.  Seasonal variation in the occurrence of pharmaceuticals in effluents from a sewage treatment plant and in the recipient water. , 2005, Environmental science & technology.

[12]  T. Heberer.  Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. , 2002, Toxicology letters.

[13]  Adriano Joss,et al.  Removal of pharmaceuticals and fragrances in biological wastewater treatment. , 2005, Water research.

[14]  N Kreuzinger,et al.  Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment. , 2004, Water science and technology : a journal of the International Association on Water Pollution Research.

[15]  Taro Urase,et al.  Factors affecting removal of pharmaceutical substances and estrogens in membrane separation bioreactors , 2005 .

[16]  Thorsten Reemtsma,et al.  Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. , 2005, Water research.

[17]  G Lyberatos,et al.  On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole. , 2005, Journal of hazardous materials.

[18]  Adriano Joss,et al.  Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. , 2006, Water research.

[19]  D. Calamari,et al.  Removal of pharmaceuticals in sewage treatment plants in Italy. , 2006, Environmental science & technology.

[20]  N Kreuzinger,et al.  Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. , 2004, Water research.

[21]  T. Ternes.  Occurrence of drugs in German sewage treatment plants and rivers 1 Dedicated to Professor Dr. Klaus , 1998 .

[22]  S. Jørgensen,et al.  Occurrence, fate and effects of pharmaceutical substances in the environment--a review. , 1998, Chemosphere.

[23]  M. Petrovíc.  Analysis and removal of emerging contaminants in wastewater and drinking water , 2003 .